Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Positrigo is a company dedicated to the development, production, and sales of dedicated brain positron emission tomography (PET) scanners.
Tribune Therapeutics specializes in building promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.
Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.
Providing RWA tokenization to traditional asset management
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.
Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.
ReelFruit is a fruit agribusiness in Nigeria.
Doctrin provides decision support systems and communication tools to healthcare providers.
Wilson Therapeutics focuses on developing novel therapies addressing unmet medical needs in rare diseases.
Tisbury Pharmaceuticals is a pre-clinical stage pharmaceutical company.
Glionova is a privately held biopharmaceutical company focused on developing new therapies for cancer.
HealthCap has invested in 37 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
HealthCap's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 18 different industry categories.
Among tracked funding rounds, SynOx Therapeutics received $92.0M in a Series B round. HealthCap's total known invested capital is $2.0B.
HealthCap's average investment size is $56.8M across its portfolio of 37 companies.
Recent HealthCap portfolio additions include Positrigo, Tribune Therapeutics, SynOx Therapeutics, Kivu Bioscience, GetEquity. These companies were founded in 2020 or later.